Medi-Tech Insights Get in touch

Global Minimal Residual Disease (MRD) Testing Market Size & Trends Report Segmented by Offering (Assay Kits/Reagents, Instruments, Services), Technology (PCR, NGS), Application (Haematological Malignancies, Solid Tumours), End-user (Hospitals, Specialty Clinics), & Regional Forecast to 2031

Request Quote Download FREE Sample
Single User

Table of Contents

  1. Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2026-2027)
  2. Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  3. Executive Summary
    • Minimal Residual Disease (MRD) Testing Market Snapshot (2026-2031)
    • Segment Overview
    • Regional Snapshot
    • Competitive In"4">
    • Market Overview
      • Market Dynamics
        • Drivers
          • Rising burden of cancer
          • Shift toward precision medicine
          • Technological advancements in molecular diagnostics
          • Increasing use of MRD as a surrogate endpoint in clinical trials
          • Growing emphasis on early detection and disease monitoring
        • Restraints
          • High cost of MRD testing
          • Limited reimbursement coverage
          • Infrastructure and skill requirements
          • Limited awareness and adoption outside major cancer centers
        • Opportunities
          • Expansion into solid tumours
          • Development of non-invasive MRD testing
          • Integration of AI and machine learning
          • Companion diagnostics and targeted therapies
        • Key Market Trends
          • Shift from traditional methods to NGS-based MRD testing
          • Integration into clinical decision-making
          • i>Unmet Market Needs
        • Industry Speaks
  1. Global Minimal Residual Disease (MRD) Testing Market Size & Forecast (2024-2031), By Offering, USD Billion
    • Introduction
    • Assay Kits & Reagents
    • Instruments
    • Services
  2. Global Minimal Residual Disease (MRD) Testing Market Size & Forecast (2024-2031), By Technology, USD Billion
    • Introduction
    • Polymerase Chain Reaction (PCR)
    • Next-generation Sequencing (NGS)
    • Flow Cytometry
    • Other Technologies
  3. Global Minimal Residual Disease (MRD) Testing Market Size & Forecast (2024-2031), By Application, USD Billion
    • Introduction
    • Haematological Malignancies
      • Leukaemia
      • Lymphoma
    • Solid Tumours
    • Multiple Myeloma
    • Other Applicatio
  4. Global Minimal Residual Disease (MRD) Testing Market Size & Forecast (2024-2031), By End User, USD Billion
    • Introduction
    • Hospitals & Specialty Clinics
    • Diagnostic Laboratories
    • Academic & Research Institutes
    • Other End Users
  5. Global Minimal Residual Disease (MRD) Testing Market Size & Forecast (2024-2031), By Region, USD Billion
    • Introduction
    • North America Minimal Residual Disease (MRD) Testing Market Size & Forecast (2024-2031), By Country, USD Billion
      • US
        • Market Size & Forecast, By Offering, (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Caarket Size & Forecast, By Offering, (USD Billion)
      • Market Size & Forecast, By Technology (USD Billion)
      • Market Size & Forecast, By Application (USD Billion)
      • Market Size & Forecast, By End User (USD Billion)
  6. Europe Minimal Residual Disease (MRD) Testing Market Size & Forecast (2024-2031), By Country, USD Billion
    • UK
      • Market Size & Forecast, By Offering, (USD Billion)
      • Market Size & Forecast, By Technology (USD Billion)
      • Market Size & Forecast, By Application (USD Billion)
      • Market Size & Forecast, By End User (USD Billion)
    • Germany
      • Market Size & Forecast, By Offering, (USD Billion)
      • Market Size & Forecast, By Technology (USD Billion)
      • Market Size & Forecast, By Application (USD Billion)
      • Market Size & Forecast, By End User (USD Billion)Ca
        • Market Size & Forecast, By Offering, (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Italy
        • Market Size & Forecast, By Offering, (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Spain
        • Market Size & Forecast, By Offering, (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Rest of Europe
        • Market Size & Forecast, By Offering, (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
    • Asia Pacific (APAC) Minimal Residual Disease (MRD) Testing Market Size & Forecast (2024-2031), By Country, USD Billion
      • China
        • Market Size & Forecast, By Offering, (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Japan
        • Market Size & Forecast, By Offering, (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • India
        • Market Size & Forecast, By Offering, (USD Billion)
        • Market Size & ForecTechnology (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
      • Rest of Asia Pacific
        • Market Size & Forecast, By Offering, (USD Billion)
        • Market Size & Forecast, By Technology (USD Billion)
        • Market Size & Forecast, By Application (USD Billion)
        • Market Size & Forecast, By End User (USD Billion)
    • Latin America (LATAM) Minimal Residual Disease (MRD) Testing Market Size & Forecast (2024-2031), USD Billion
      • Market Size & Forecast, By Offering, (USD Billion)
      • Market Size & Forecast, By Technology (USD Billion)
      • Market Size & Forecast, By Application (USD Billion)
      • Market Size & Forecast, By End User (USD Billion)
    • Middle East & Africa (MEA) Minimal Residual Disease (MRD) Testing Market Size & Forecast (2024-2031), USllion
      • Market Size & Forecast, By Offering, (USD Billion)
      • Market Size & Forecast, By Technology (USD Billion)
      • Market Size & Forecast, By Application (USD Billion)
      • Market Size & Forecast, By End User (USD Billion)
  1. Competitive Landscape
    • Key Players and their Competitive Positioning
      • Key Player Comparison
      • Segment-wise Player Mapping
      • Market Share Analysis (2025)
      • Company Categorization Matrix
        • Dominants/Leaders
        • New Entrants
        • Emerging Players
        • Innovative Players
      • Key Strategies Assessment, By Player (2023-2026)
        • New Product and Service Launches
        • Partnerships, Agreements, & Collaborations
        • Mergers & Acquisitions
        • Geographic Expansion
  1. Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
  • Hoffmann-La Roche Ltd
  • Labcorp
  • Guardant Health, Inc.
  • Adaptive Biotechnologies
  • Natera, Inc.
  • Exact Sciences Corporation
  • QIAGEN
  • Bio-Rad Laboratories, Inc
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Other Prominent Players
Note: *Indicative list **For listed companies

Related Reports

View All Research Reports